Cancer Center Support

描述（由申请人提供）：匹兹堡大学癌症研究所（UPCI）是一个多学科的癌症研究中心，在基础研究，转化研究和临床研究计划;癌症控制和人口科学，早期诊断和治疗，以及行为医学研究。 除了在匹兹堡大学的所有癌症研究中发挥核心作用外，它还全面负责癌症教育和最近显着扩大的临床护理网络。 UPCI由匹兹堡大学的教师组成，一些成员也来自附近的卡内基梅隆大学，它利用匹兹堡大学医学中心（UPMC）和UPMC癌症中心的临床设施。UPCI已经建立了以下项目：分子和细胞肿瘤学，分子治疗学和药物发现，免疫学，分子病毒学，肺和胸部恶性肿瘤，前列腺癌和泌尿系统癌症，头颈癌，生物治疗学，脑肿瘤;癌症流行病学，预防和控制;行为医学和肿瘤学。 为了协助其研究工作，UPCI维护共享设施，包括：生物统计学、临床研究服务、免疫学监测实验室、细胞产品实验室、流式细胞术、肽合成、动物、玻璃器皿、寡核苷酸、细胞和组织成像、PET、MRI、基础基因组学和蛋白质组学、临床蛋白质组学、载体、转基因和嵌合小鼠、组织和研究病理学服务（TARPS），临床药理学和分析，癌症信息学服务，研究药物服务和微阵列和分析共享服务（MASS）。 本申请要求继续癌症中心支持补助金（CCSG）资助匹兹堡大学癌症研究所的计划17-22年。

DESCRIPTION (provided by applicant): The University of Pittsburgh Cancer Institute (UPCI) is a multidisciplinary cancer research center, with programs in basic research, translational research and clinical investigations; cancer control and population sciences, early diagnosis and treatment, and behavioral medicine research. In addition to its central role in all cancer research at the University of Pittsburgh, it has full responsibility for cancer education and a recently significantly expanded network of clinical care. The UPCI is comprised of faculty members from the University of Pittsburgh, with some members also from the nearby Carnegie Mellon University, and it utilizes the clinical facilities of the University of Pittsburgh Medical Center (UPMC) and UPMC Cancer Centers. The UPCI has established programs in: molecular and cellular oncology, molecular therapeutics and drug discovery, immunology, molecular virology, lung and thoracic malignancies, prostate and urologic cancers, head and neck cancer, biological therapeutics, brain tumors; cancer epidemiology, prevention and control; and behavioral medicine and oncology. To assist its research efforts, the UPCI maintains shared facilities including: Biostatistics, Clinical Research Services, Immunologic Monitoring Laboratory, Cellular Products Laboratory, Flow Cytometry, Peptide Synthesis, Animal, Glassware, Oligonucleotide, Cell and Tissue Imaging, PET, MRI, Basic Genomics and Proteomics, Clinical Proteomics, Vector, Transgenic and Chimeric Mouse, Tissue and Research Pathology Services (TARPS), Clinical Pharmacology and Analytical, Cancer Informatics Services, Investigational Drug Service, and Micro-array and Analysis Shared Services(MASS). This application requests continued cancer center support grant (CCSG) funding for the University of Pittsburgh Cancer Institute's program for years 17-22.